7 unknown, 3 completed, 1 enrolling by invitation, 1 recruiting. 4 Phase 1, 2 Early Phase 1, 2 Phase 4, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 3, Completed 1 |
| Early Phase 1 | 2 | Enrolling by invitation 1, Unknown 1 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Not applicable | 1 | Unknown 1 |
Follow BGI, China: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Spatially Resolved IBD: Spatial Transcriptomics of Inflammatory Bowel Disease (IBD) transcriptomic analysis - Patients With Histologically Confirmed CD Undergoing Intestinal Resection According to Standard of Care Due to Complicating Disease, Patients With Histologically Confirmed UC Undergoing Intestinal Resection According to Standard of Care Due to Complicating Disease | Unknown | IRCCS San Raffaele | 16 | 2024-08-01 | 2024-07-03 | |
| Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL) targeted AML1-ETO neoantigen cytotoxic T cells (CTL), Cyclophosphamide injection, Decitabine Injection - AML, t(8;21) | Early Phase 1 | Enrolling by invitation | BGI, China | 16 | 2024-02-01 | 2025-08-28 |
| Treatment of Relapsed or Refractory Epstein-Barr Virus Positive T-cell Lymphoma With hNeo-T hNeo-T, Cyclophosphamide, Fludarabine - T-cell Lymphoma | Early Phase 1 | Unknown | BGI, China | 6 | 2023-12-01 | 2024-03-12 |
| A Prospective Study on the Application of Liquid Biopsy in the Surveillance of High-risk Population of HCC. ultrasonic testing - Hepatocellular Carcinoma | Unknown | Tianjin Third Central Hospital | 1000 | 2023-09-01 | 2023-11-22 | |
| HPV-T in HPV-16 Positive Recurrent or Metastatic Solid Tumors HPV-T, Interleukin-2 - Solid Tumor | Phase 1 | Unknown | BGI, China | 12 | 2023-04-13 | 2023-06-08 |
| Neo-T in Treating Patients With Advanced Solid Tumors(GI-NeoT-03) Neo-T, Toripalimab, Tislelizumab - Solid Tumor | Phase 1 | Unknown | BGI, China | 6 | 2023-01-10 | 2023-07-10 |
| Treatment of Advanced Solid Tumors With Neo-T(GI-NeoT-02) Neo-T, Cyclophosphamide, Fludarabine - Solid Tumor | Phase 1 | Unknown | BGI, China | 21 | 2022-09-28 | 2023-04-04 |
| A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis Metronidazole vaginal suppositories, Metronidazole vaginal suppositories and Probiotics(Umeta-mimi) - Bacterial Vaginosis | Phase 4 | Recruiting | Peking University Shenzhen Hospital | 140 | 2020-02-01 | 2025-06-12 |
| Probiotics as Adjuvant Treatment for Bacterial Vaginosis "Probiotics" and "Metronidazole", Metronidazole Vaginal - Bacterial Vaginosis | Phase 4 | Completed | Peking University Shenzhen Hospital | 126 | 2019-03-26 | 2021-07-09 |
| TSA-DC Vaccine in Treating Patients With Gastrointestinal Solid Tumor Tumor Specific Antigen-loaded Dendritic Cells, Cyclophosphamide - Tumor Gastric, Tumor, Colorectal | Not applicable | Unknown | BGI, China | 20 | 2017-12-01 | 2017-08-14 |
| Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes) TSA-CTL, Cyclophosphamide, Fludarabine - Solid Cancer | Phase 1 | Completed | BGI, China | 11 | 2016-12-22 | 2023-02-02 |
| Colon Cancer Study of Fecal Samples in Shanghai, China Colorectal Neoplasms | Completed | National Cancer Institute (NCI) | 68 | 2013-01-08 | 2018-04-05 |
Colorectal Neoplasms (3) · Melanoma (3) · Carcinoma, Non-Small-Cell Lung (2) · Vaginosis, Bacterial (2) · Carcinoma, Hepatocellular (1) · Epstein-Barr Virus Infections (1) · Lymphoma, T-Cell (1) · Recurrence (1) · Stomach Neoplasms (1) · Uterine Cervical Neoplasms (1)
Cyclophosphamide (5) · fludarabine (3) · Infusions, Intravenous (2) · Interleukin-2 (2) · Decitabine (1) · Metronidazole (1) · Probiotics (1) · fludarabine phosphate (1) · tislelizumab (1) · toripalimab (1)
China (10) · Italy (1)
LiXin Wang, Doctor (2) · Ruifang Wu, M.D. (2) · Fengmei Wang, PhD (1) · James J Goedert, M.D. (1) · Jian Zhang, Doctor (1) · Jing Chen, Doctor (1) · Qing Xu, Doctor (1) · Xiao Sh Zhang, Doctor (1) · Yong Chen, Doctor (1) · ZengQing Guo, Professor (1)
PMID 24812403, PMID 25837513, PMID 27312342, PMID 37301885, PMID 37575226